United States · FDA National Drug Code directory
Thiotepa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9565_74c9ff27-7c88-4dff-831d-eab4b8d9f1d7
- Product NDC
- 0143-9565
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Thiotepa
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20010601
- Source listing expiry
- 20261231
Source-listed ingredients
- THIOTEPA — 15 mg/1.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 BOX, UNIT-DOSE (0143-9565-01) / 1.5 mL in 1 VIAL · 0143-9565-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →